“…More than 50% of exposed persons may develop symptoms and signs of immediatetype allergy such as conjunctivitis, rhinitis, asthma bronchiale or urticaria [2][3][4], Characterization and clinical rel evance of other cutaneous complaints including pruritus and dermatitis are uncertain [2,3,8]. The diagnosis of Pt-related occupational disease can be confirmed by skin prick test or bronchoprovocation eliciting immedi ate-type reactions to minute doses (10~2 to 10"8 mol/l) of [Pt(IV)Cl6]2-or [Pt(II)Cl4]2- [5,7,9], In contrast to the highly specific but hazardous in vivo tests, attempts to elu cidate the nature of these reactions by demonstrating Ptspecific serum IgE or IgG antibodies in vitro remained in conclusive [7,10], even though elevated total IgE levels were found in Pt-exposed refinery workers [5][6][7], Further more, it has been shown that Pt salts are able to elicit non specific histamine release from human basophils in vitro [71.…”